Henry Schein, Inc. (HSIC)
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits
Ananym Capital is calling for changes at Henry Schein, which may help the company improve its profitability.
HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes.
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, sources close to matter said on Monday.
Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits
Henry Schein shares climbed more than 4% in Monday trading, on track to notch their best day since July. Financial firm Gordon Haskett said Robert F.
Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript
Henry Schein, Inc. (NASDAQ:HSIC ) Q3 2024 Earnings Conference Call November 5, 2024 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - Chairman & CEO Ronald South - SVP and CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Jeffrey Johnson - Baird Kevin Caliendo - UBS Jonathan Block - Stifel Jason Bednar - Piper Sandler John Stansel - JPMorgan Brandon Vazquez - William Blair Michael Petusky - Barrington Research Operator Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Henry Schein (HSIC) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HSIC Q3 Earnings Top, Margins Down, Stock Gains in Premarket
Henry Schein's third-quarter results reflect an improvement in sales trends in Technology and Value-Added Services business.
Henry Schein (HSIC) Q3 Earnings Top Estimates
Henry Schein (HSIC) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.32 per share a year ago.
Henry Schein beats quarterly profit estimates on lower costs
Dental products distributor Henry Schein beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and slow recovery from a cyberattack it disclosed in October last year.
Unlocking Q3 Potential of Henry Schein (HSIC): Exploring Wall Street Estimates for Key Metrics
Get a deeper insight into the potential performance of Henry Schein (HSIC) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Henry Schein (HSIC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
